News

UroToday8d
ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
In Q1, the company submitted a supplemental Biologics License Application (sBLA) for use of ANKTIVA® plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) ...
UroToday7d
Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting
• Ultra-low PSA Response (<0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes Interactive Poster Session: IP26-07; April 29, 9:30-11:30 a.m. PDT ...
UroToday7d
How are we Getting Paid for Theranostics and Dosimetry? "Presentation" - Denise Merlino
How are we Getting Paid for Theranostics and Dosimetry? "Presentation" - Denise Merlino ...
UroToday6d
Dry Mouth Prevention and Management for PSMA Radioligand Therapy "Presentation" - Sue Yom
Dry Mouth Prevention and Management for PSMA Radioligand Therapy "Presentation" - Sue Yom ...
UroToday3d
Is Partial Nephrectomy A Primary Option for Patients with T1b Renal Cell Carcinoma-A National Population-Based Study.
Renal cell carcinoma (RCC) patients in clinical T1 RCC generally exhibit a favorable prognosis. Guidelines recommend partial nephrectomy (PN), also for cT1b RCCs. Despite a favorable prognosis, there ...
UroToday3d
Robot-assisted tubeless radical cystectomy: Is the absence of ureteral drainage a mistake?
Radical cystectomy is the gold standard technique for muscle-invasive bladder cancer and resistant non muscle-invasive bladder cancer. This surgery presents a high rate of complications despite the ...
UroToday3d
ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor with Distinctive Genomic Characteristics.
ELOC-mutated renal cell carcinoma (ELOC-RCC) is a subtype of renal cell carcinoma (RCC) first recognized by the World Health Organization in 2022, molecularly defined by the presence of ELOC mutations ...
UroToday3d
Outcomes of Focal Therapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies.
Focal therapies (FTs) for localized prostate cancer (PCa) are recommended only within prospective registries or clinical trials. In this systematic review and meta-analysis, we aimed to synthesize ...
UroToday3d
Kidney sparing surgery versus radical nephroureterectomy in upper tract urothelial carcinoma: a meta-analysis and systematic review.
Kidney-sparing surgery (KSS) has been increasingly performed in patients with upper tract urothelial carcinoma (UTUC) in recent years. We aim to conduct a systematic review and meta-analysis comparing ...
UroToday4d
Influence of preoperative indwelling urinary catheter on outcomes of high-power holmium laser enucleation for very large prostate (≥ 200 mL).
to evaluate the impact of Indwelling Urinary Catheters (IUC) on perioperative and functional outcomes, as well as the safety profile, of High-Power HoLEP for the treatment of prostate gland volumes ...
UroToday4d
External Urinary Devices for Stress Urinary Incontinence: Does One Size Fit All?
Both males and females can be effected by stress urinary incontinence (SUI), with symptoms ranging from mild to severe. External urinary devices (EUDs) can help in managing incontinence in daily life ...
UroToday4d
Shared Decision-Making (SDM) for Female SUI: Current Practice in Three Western Countries.
Different decision-making styles can be used to provide counselling for the multiple reasonable treatment options for patients with stress urinary incontinence (SUI). Shared decision-making (SDM) is ...